Fenikso Limited (AQU:FNK)
London · Delayed Price · Currency is GBP · Price in GBX 1.800
0.00 (0.00%)
At close: Jul 30, 2025
Blueprint Medicines Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Cash & Equivalents | 2.7 | 2.6 | 0.21 | 0.05 | 3.03 | Upgrade |
Cash & Short-Term Investments | 2.7 | 2.6 | 0.21 | 0.05 | 3.03 | Upgrade |
Cash Growth | 3.77% | 1151.44% | 316.00% | -98.35% | 10.87% | Upgrade |
Accounts Receivable | - | - | - | - | 1.13 | Upgrade |
Other Receivables | 25.05 | 26.59 | 31.21 | - | 0.14 | Upgrade |
Receivables | 25.05 | 26.59 | 31.21 | - | 2.8 | Upgrade |
Inventory | - | - | - | - | 1 | Upgrade |
Prepaid Expenses | - | - | - | - | 0.35 | Upgrade |
Restricted Cash | - | - | - | - | 1.72 | Upgrade |
Other Current Assets | - | - | - | - | 0.03 | Upgrade |
Total Current Assets | 27.75 | 29.19 | 31.42 | 0.05 | 8.93 | Upgrade |
Property, Plant & Equipment | - | - | - | - | 53.34 | Upgrade |
Long-Term Investments | 0.86 | - | - | - | - | Upgrade |
Other Intangible Assets | - | - | - | - | 1.96 | Upgrade |
Long-Term Deferred Tax Assets | - | - | - | - | 17.46 | Upgrade |
Other Long-Term Assets | - | - | - | 51.92 | 25.54 | Upgrade |
Total Assets | 28.61 | 29.19 | 31.42 | 51.97 | 107.21 | Upgrade |
Accounts Payable | 0.04 | 0.47 | 1.5 | 1.02 | 11.16 | Upgrade |
Accrued Expenses | 0.09 | 0.23 | 0.99 | 0.27 | 11.07 | Upgrade |
Short-Term Debt | - | - | - | 0.24 | - | Upgrade |
Current Portion of Long-Term Debt | 3.27 | 2.78 | 2.02 | - | 5.8 | Upgrade |
Current Income Taxes Payable | 0.11 | - | - | - | 2.2 | Upgrade |
Other Current Liabilities | 0.36 | - | - | - | 10.85 | Upgrade |
Total Current Liabilities | 3.86 | 3.49 | 4.5 | 1.53 | 41.08 | Upgrade |
Long-Term Debt | 4.49 | 6.02 | 7.4 | 16.26 | 8.35 | Upgrade |
Other Long-Term Liabilities | - | - | - | - | 2.39 | Upgrade |
Total Liabilities | 8.36 | 9.51 | 11.9 | 17.78 | 51.82 | Upgrade |
Common Stock | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | Upgrade |
Additional Paid-In Capital | 264.73 | 264.73 | 264.73 | 264 | 264 | Upgrade |
Retained Earnings | -244.16 | -245.08 | -245.24 | -229.84 | -203.27 | Upgrade |
Treasury Stock | -0.34 | - | - | - | - | Upgrade |
Comprehensive Income & Other | - | - | - | - | 10.29 | Upgrade |
Total Common Equity | 20.25 | 19.68 | 19.52 | 34.19 | 71.05 | Upgrade |
Minority Interest | - | - | - | - | -15.66 | Upgrade |
Shareholders' Equity | 20.25 | 19.68 | 19.52 | 34.19 | 55.39 | Upgrade |
Total Liabilities & Equity | 28.61 | 29.19 | 31.42 | 51.97 | 107.21 | Upgrade |
Total Debt | 7.76 | 8.81 | 9.42 | 16.49 | 14.15 | Upgrade |
Net Cash (Debt) | -5.06 | -6.2 | -9.21 | -16.44 | -11.12 | Upgrade |
Net Cash Per Share | -0.01 | -0.01 | -0.02 | -0.03 | -0.02 | Upgrade |
Filing Date Shares Outstanding | 473.14 | 492.95 | 599.4 | 536.78 | 536.53 | Upgrade |
Total Common Shares Outstanding | 473.14 | 492.95 | 599.4 | 536.78 | 536.53 | Upgrade |
Working Capital | 23.88 | 25.7 | 26.92 | -1.48 | -32.15 | Upgrade |
Book Value Per Share | 0.04 | 0.04 | 0.03 | 0.06 | 0.13 | Upgrade |
Tangible Book Value | 20.25 | 19.68 | 19.52 | 34.19 | 69.09 | Upgrade |
Tangible Book Value Per Share | 0.04 | 0.04 | 0.03 | 0.06 | 0.13 | Upgrade |
Machinery | - | - | - | - | 2.21 | Upgrade |
Leasehold Improvements | - | - | - | - | 0.91 | Upgrade |
Updated Sep 30, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.